Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|March 1, 1988
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndromeP Rogers, C J Allegra, R F Murphy, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapyW H Wilson, C Jamis-Dow, G Bryant, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomataB A Chabner, R E Johnson, P B Chretien, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
The Oncologist|August 31, 2000
Sexuality and cancer: conversation comfort zoneR T Penson, J Gallagher, M E Gioiella, et al.
American Journal of Clinical Oncology|February 1, 1992
Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group studyD H Ryan, K J Kopecky, D Head, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemiaB D Cheson, P A Cassileth, D R Head, et al.
Science (New York, N.Y.)|October 16, 1992
Neural computing in cancer drug development: predicting mechanism of actionJ N Weinstein, K W Kohn, M R Grever, et al.
Leukemia Research|September 4, 1999
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.
Pageof 21